Found: 45
Select item for more details and to access through your institution.
SWIFT clustering analysis of intracellular cytokine staining flow cytometry data of the HVTN 105 vaccine trial reveals high frequencies of HIV-specific CD4+ T cell responses and associations with humoral responses.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1347926
- By:
- Publication type:
- Article
CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus Macaques.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.757811
- By:
- Publication type:
- Article
Maintenance of Viral Suppression in Human Immunodeficiency Virus Controllers Despite Waning T-Cell Responses During Antiretroviral Therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-69007-w
- By:
- Publication type:
- Article
Self-Reported Experiences of Racial Discrimination Among African Americans in Upstate New York.
- Published in:
- Journal of Black Studies, 2020, v. 51, n. 5, p. 481, doi. 10.1177/0021934720925786
- By:
- Publication type:
- Article
Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus–Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 11, p. 1712, doi. 10.1093/cid/ciy242
- By:
- Publication type:
- Article
First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1.
- Published in:
- PLoS ONE, 2018, v. 13, n. 11, p. 1, doi. 10.1371/journal.pone.0205139
- By:
- Publication type:
- Article
Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 10, p. N.PAG, doi. 10.1093/ofid/ofy242
- By:
- Publication type:
- Article
Curaxin CBL0100 Blocks HIV-1 Replication and Reactivation through Inhibition of Viral Transcriptional Elongation.
- Published in:
- Frontiers in Microbiology, 2017, p. 1, doi. 10.3389/fmicb.2017.02007
- By:
- Publication type:
- Article
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pre-existing neutralizing antibody mitigates B cell dysregulation and enhances the Env-specific antibody response in SHIV-infected rhesus macaques.
- Published in:
- PLoS ONE, 2017, v. 12, n. 2, p. 1, doi. 10.1371/journal.pone.0172524
- By:
- Publication type:
- Article
Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0158641
- By:
- Publication type:
- Article
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0136626
- By:
- Publication type:
- Article
Capacity Building Among African American Faith Leaders to Promote HIV Prevention and Vaccine Research.
- Published in:
- Progress in Community Health Partnerships, 2014, v. 8, n. 3, p. 265, doi. 10.1353/cpr.2014.0035
- By:
- Publication type:
- Article
Capacity Building Among African American Faith Leaders to Promote HIV Prevention and Vaccine Research.
- Published in:
- Progress in Community Health Partnerships, 2014, v. 8, n. 3, p. 305, doi. 10.1353/cpr.2014.0050
- By:
- Publication type:
- Article
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Broad HIV Epitope Specificity and Viral Inhibition Induced by Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0090378
- By:
- Publication type:
- Article
9G4+ Antibodies Isolated from HIV-Infected Patients Neutralize HIV-1 and Have Distinct Autoreactivity Profiles.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0085098
- By:
- Publication type:
- Article
Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery.
- Published in:
- Journal of Infectious Diseases, 2013, v. 208, n. 5, p. 818, doi. 10.1093/infdis/jit236
- By:
- Publication type:
- Article
Bridging the Digital Divide in HIV Care: A Pilot Study of an iPod Personal Health Record.
- Published in:
- Journal of the International Association of Providers of AIDS Care, 2013, v. 12, n. 2, p. 117, doi. 10.1177/1545109712457712
- By:
- Publication type:
- Article
Barriers and Facilitators of Online Patient Portals to Personal Health Records Among Persons Living With HIV: Formative Research.
- Published in:
- Journal of Medical Internet Research, 2013, v. 15, n. 1, p. 8, doi. 10.2196/resprot.2302
- By:
- Publication type:
- Article
Prospective Surveillance for Cardiac Adverse Events in Healthy Adults Receiving Modified Vaccinia Ankara Vaccines: A Systematic Review.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0054407
- By:
- Publication type:
- Article
A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0041936
- By:
- Publication type:
- Article
9G4 Autoreactivity Is Increased in HIV-Infected Patients and Correlates with HIV Broadly Neutralizing Serum Activity.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0035356
- By:
- Publication type:
- Article
Immunization with Cocktail of HIV-Derived Peptides in Montanide ISA-51 Is Immunogenic, but Causes Sterile Abscesses and Unacceptable Reactogenicity.
- Published in:
- PLoS ONE, 2010, v. 5, n. 8, p. 1, doi. 10.1371/journal.pone.0011995
- By:
- Publication type:
- Article
Comparative Cell-Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV-1 Clade B gag Vaccine Prime-Boost Regimens.
- Published in:
- Journal of Infectious Diseases, 2010, v. 201, n. 1, p. 132, doi. 10.1086/648591
- By:
- Publication type:
- Article
High-Dose Recombinant Canarypox Vaccine Expressing HIV-1 Protein, in Seronegative Human Subjects.
- Published in:
- Journal of Infectious Diseases, 2005, v. 192, n. 7, p. 1249
- By:
- Publication type:
- Article
Breakthrough Infections during Phase 1 and 2 Prime-Boost HIV-1 Vaccine Trials with Canarypox Vectors (ALVAC) and Booster Dose of Recombinant gp120 or gp160.
- Published in:
- Journal of Infectious Diseases, 2004, v. 190, n. 5, p. 903, doi. 10.1086/423284
- By:
- Publication type:
- Article
Comparison of Systemic and Mucosal Delivery of 2 Canarypox Virus Vaccines Expressing either HIV-1 Genes or the Gene for Rabies Virus G Protein.
- Published in:
- Journal of Infectious Diseases, 2004, v. 189, n. 7, p. 1221
- By:
- Publication type:
- Article
Immunization with Envelope MN rgp120 Vaccine in Human Immunodeficiency Virus-Infected Pregnant Women.
- Published in:
- Journal of Infectious Diseases, 1999, v. 180, n. 4, p. 1080, doi. 10.1086/314985
- By:
- Publication type:
- Article
A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8[sup+] Cytotoxic T Lymphocyte Responses in Seronegative Volunteers.
- Published in:
- Journal of Infectious Diseases, 1999, v. 180, n. 2, doi. 10.1086/314895
- By:
- Publication type:
- Article
Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV-1MN gp120, HIV-1SF2 Recombinant gp120, or Both Vaccines in Seronegative Adults.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 5, p. 1230
- By:
- Publication type:
- Article
Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 2, p. 310, doi. 10.1086/514209
- By:
- Publication type:
- Article
Longitudinal Analysis of Quantitative Virologic Measures in Human Immunodeficiency Virus-Infected Subjects with ⩾400 CD4 Lymphocytes: Implications for Applying Measurements to Individual Patients.
- Published in:
- Journal of Infectious Diseases, 1997, v. 175, n. 2, p. 247
- By:
- Publication type:
- Article
Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: Recombinant...
- Published in:
- Annals of Internal Medicine, 1996, v. 125, n. 4, p. 270, doi. 10.7326/0003-4819-125-4-199608150-00003
- By:
- Publication type:
- Article
A Dose-Ranging Study of a Prototype Synthetic HIV-1MN V3 Branched Peptide Vaccine.
- Published in:
- Journal of Infectious Diseases, 1996, v. 173, n. 2, p. 330
- By:
- Publication type:
- Article
Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1.
- Published in:
- Journal of Infectious Diseases, 1996, v. 173, n. 2, p. 340
- By:
- Publication type:
- Article
Interpreting HIV Serodiagnostic Test Results in the 1990s: Social Risks of HIV Vaccine Studies in Uninfected Volunteers .
- Published in:
- Annals of Internal Medicine, 1994, v. 121, n. 8, p. 584, doi. 10.7326/0003-4819-121-8-199410150-00005
- By:
- Publication type:
- Article
Determinants Of Antibody Response After Recombinant Gp160 Boosting In Vaccinia-Naive Volunteers Primed With Gp160-Recombinant Vaccinia Virus.
- Published in:
- Journal of Infectious Diseases, 1994, v. 170, n. 4, p. 782
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Fully Glycosylated Recombinant gp160 Human Immunodeficiency Virus Type 1 Vaccine in Subjects at Low Risk of Infection.
- Published in:
- Journal of Infectious Diseases, 1993, v. 168, n. 6, p. 1387, doi. 10.1093/infdis/168.6.1387
- By:
- Publication type:
- Article
Persisting Human Immunodeficiency Virus Type 1 gp160-Specific Human T Lymphocyte Responses Including CD8+ Cytotoxic Activity after Receipt of Envelope Vaccines.
- Published in:
- Journal of Infectious Diseases, 1993, v. 168, n. 2, p. 306
- By:
- Publication type:
- Article
Augmentation of Human Immunodeficiency Virus Type 1 Neutralizing Antibody by Priming with gp160 Recombinant Vaccinia and Boosting with gp160 in Vaccinia-Naive Adults.
- Published in:
- Journal of Infectious Diseases, 1993, v. 167, n. 3, p. 533, doi. 10.1093/infdis/167.3.533
- By:
- Publication type:
- Article
Vaccination of Vaccinia-Naive Adults with Human Immunodeficiency Virus Type 1 gp160 Recombinant Vaccinia Virus in a Blinded, Controlled, Randomized Clinical Trial.
- Published in:
- Journal of Infectious Diseases, 1992, v. 166, n. 2, p. 244, doi. 10.1093/infdis/166.2.244
- By:
- Publication type:
- Article
Human Immunodeficiency Virus (HIV-l) gp160-Specific Lymphocyte Proliferative Responses of Mononuclear Leukocytes from HIV-l Recombinant gp160 Vaccine Recipients.
- Published in:
- Journal of Infectious Diseases, 1991, v. 163, n. 3, p. 448, doi. 10.1093/infdis/163.3.448
- By:
- Publication type:
- Article